December 3, 2025 — Leads & Copy —
NEW HAVEN, Conn. — BioXcel Therapeutics, Inc. will sponsor a virtual roundtable on Monday, Dec. 8, at 10 a.m. EST, to discuss the future of acute agitation treatment for patients with bipolar disorder and schizophrenia. The discussion will highlight the potential for safe, effective self-administered treatments at home, as millions of patients and caregivers grapple with these episodes.
Award-winning healthcare journalist Anjalee Khemlani, known for her reporting at Yahoo Finance and NJBIZ, will host the one-hour event. Interested individuals can pre-register at https://event.webcasts.com/starthere.jsp?ei=1744467&tp_key=14d071615e.
With an estimated 57 to 77 million at-home agitation episodes linked to bipolar disorders and schizophrenia occurring annually in the U.S., the roundtable intends to provide clinicians, caregivers, investors, and healthcare professionals insights into the changing treatment approaches and emerging innovations that could transform patient care beyond traditional settings like emergency rooms, psychiatric facilities, and skilled nursing facilities.
Roundtable participants include:
Leslie Citrome, M.D., M.P.H., Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College.
Marc A. Milano, M.D., FACEP, Chair, Department of Emergency Medicine at Newark Beth Israel Medical Center and Children’s Hospital of New Jersey.
Leon Ravin, M.D., Psychiatrist and Statewide Psychiatric Medical Director for the Division of Public and Behavioral Health, State of Nevada.
Attendees can submit questions via written Q&A. A recording will be available on the BioXcel Therapeutics website.
Contact Information:
Corporate/Investors
Russo Partners
Nic Johnson
nic.johnson@russopartnersllc.com
1.303.482.6405
Media
Russo Partners
David Schull
david.schull@russopartnersllc.com
1.858.717.2310
Source: BioXcel Therapeutics, Inc.
